These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 8764363

  • 1. Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension.
    Melaragno MG, Fink GD.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):297-303. PubMed ID: 8764363
    [Abstract] [Full Text] [Related]

  • 2. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
    Guidi E, Hollenberg NK.
    J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM, Kemp PA, Brunner-Ferber F, Bennett T.
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [Abstract] [Full Text] [Related]

  • 6. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK, Drew GM.
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [Abstract] [Full Text] [Related]

  • 7. Effect of perindopril on renal medullary blood flow: comparison with other antihypertensive treatments.
    Issiakhem M, Liu KL, Benzoni D.
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):280-5. PubMed ID: 18356693
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin II increases tissue-specific inhibitor of metalloproteinase-2 expression in rat aortic smooth muscle cells in vivo: evidence of a pressure-independent effect.
    Castoldi G, di Gioia CR, Travaglini C, Busca G, Redaelli S, Bombardi C, Stella A.
    Clin Exp Pharmacol Physiol; 2007 Mar; 34(3):205-9. PubMed ID: 17250640
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 11. Anterior hypothalamic beta-adrenoceptors in chronic aortic-coarctated hypertensive rats: an interaction with central angiotensin II receptors.
    Höcht C, Opezzo JA, Gironacci MM, Peña C, Taira CA.
    Clin Exp Pharmacol Physiol; 2005 Jun 15; 32(1-2):30-4. PubMed ID: 15730431
    [Abstract] [Full Text] [Related]

  • 12. Impaired baroreflex sensitivity and responses to angiotensin converting enzyme inhibitor in salt-induced hypertension and its prevention by dietary calcium supplement in Sprague-Dawley rats.
    Ladipo CO, Egbe PE, Ibu JO.
    Afr J Med Med Sci; 2006 Mar 15; 35(1):29-36. PubMed ID: 17209324
    [Abstract] [Full Text] [Related]

  • 13. Renal denervation attenuates long-term hypertensive effects of Angiotensin ii in the rat.
    Hendel MD, Collister JP.
    Clin Exp Pharmacol Physiol; 2006 Dec 15; 33(12):1225-30. PubMed ID: 17184505
    [Abstract] [Full Text] [Related]

  • 14. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 15; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of angiotensin-converting enzyme inhibition on coronary vasomotion in hypertensive patients.
    Nitenberg A, Antony I.
    Eur Heart J; 1998 Sep 15; 19 Suppl J():J45-51. PubMed ID: 9796840
    [Abstract] [Full Text] [Related]

  • 16. Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension.
    Rugale C, Cordaillat M, Mimran A, Jover B.
    J Renin Angiotensin Aldosterone Syst; 2005 Dec 15; 6(3):154-60. PubMed ID: 16525947
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F, Kuru O, Sentürk UK.
    Int J Sports Med; 2005 Nov 15; 26(9):710-3. PubMed ID: 16237614
    [Abstract] [Full Text] [Related]

  • 18. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
    García-Estañ J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM.
    Clin Sci (Lond); 2006 Feb 15; 110(2):227-33. PubMed ID: 16197366
    [Abstract] [Full Text] [Related]

  • 19. [Antihypertensive activity of monoclonal antibody to angiotensin II].
    Su Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Jun 15; 19(3):180-2, 198. PubMed ID: 1914865
    [Abstract] [Full Text] [Related]

  • 20. Coronary hemodynamics and the renin angiotensin system.
    Magrini F, Reggiani P, Paliotti R, Bonagura F, Ciulla M, Vandoni P.
    Clin Exp Hypertens; 1993 Jun 15; 15 Suppl 1():139-55. PubMed ID: 8513306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.